Background Many countries now off er support to teenage mothers to help them to achieve long-term socioeconomic stability and to give a successful start to their children. The Family Nurse Partnership (FNP) is a licensed intensive home-visiting intervention developed in the USA and introduced into practice in England that involves up to 64 structured home visits from early pregnancy until the child's second birthday by specially recruited and trained family nurses. We aimed to assess the eff ectiveness of giving the programme to teenage fi rst-time mothers on infant and maternal outcomes up to 24 months after birth.
Introduction
Individual, social, and economic circumstances faced by teenage mothers can challenge a successful start for children and interrupt mothers' long-term socioeconomic stability. Children of teenage mothers are more likely to have lower birthweight, not be breastfed, be at greater risk of accidents and early death, do worse educationally, have more emotional and behavioural problems, and become teenage parents themselves. [1] [2] [3] [4] Inter vention early in the lives of families with young mothers might enhance life chances for both mother and child. [5] [6] [7] [8] Several home-visiting interventions have been introduced to support families, with evidence of their benefi t mostly reported from the USA. 9 Programmes typically address multiple maternal and child outcomes and can improve birth outcomes, cognitive and socio economic development, use of preventive health care, and reduce potential abuse (eg, injuries, ingestions, and emergency department attendances) and maltreatment. [10] [11] [12] [13] In England, the Healthy Child Programme (HCP) forms the universal off er of clinical and public health for children and families during pregnancy to adulthood. 14 Specifi c programmes to support children growing up in disadvantaged circumstances have included area-based Sure Start local programmes and the more targeted Sure Start Plus schemes for pregnant teenage girls. [15] [16] [17] In 2006, the UK Government announced its intention to test the Family Nurse Partnership (FNP) programme, University of Colorado, Denver, CO, USA, as an intensive preventive home-visiting service. FNP was initially adapted from the US Nurse Family Partnership programme, one of 12 programmes meeting criteria for an evidence-based model. 13,18-21 FNP is a fee-based programme available only under licence, with the intellectual property owned by the University of Colorado who retain authority for approving any alterations. Three US evaluations (in Elmira [NY], Memphis [TN] , and Denver [CO]) have taken place, as well as one in the Netherlands, with positive results for mothers and babies. 18, [20] [21] [22] For roll-out in England, an implementation evaluation in ten sites involving fi rst-time pregnant women aged up to 23 years at enrolment preceded our trial and reported evaluation results (pregnancy and post-partum period) focused on feasibility and acceptability from 2008. [23] [24] [25] As the third phase of a model of international replication (after adaptation and pilot testing phases), we aimed to establish the eff ectiveness of FNP when delivered in a broadly based, publicly funded, health-care setting.
Methods

Study design and participants
We did a pragmatic, open-label, individually randomised controlled trial to compare usual care (through primarycare public health and social care services) plus FNP (FNP group) to usually provided health and social care alone (usual care group). The protocol has been published. 26 The 18 study sites were partnerships of primary and secondary
Research in context
Evidence before this study We reviewed the existing trial evidence in May, 2008. Because intellectual property is owned by the University of Colorado, all previous trials were restricted to the three US evaluations (in Elmira [NY] , Memphis [TN] , and Denver [CO]). As is commonly found in home-visiting evaluations, each trial in the USA identifi ed multiple outcomes and was not formally adjusted for multiple signifi cance testing. The trials reported positive eff ects in prenatal health behaviours, birth outcomes, sensitive child care, child and adolescent functioning, and maternal lifecourse. Two outcomes with prior replicated positive eff ects by 24 months post-partum are changes in smoking and second pregnancy. In Elmira, the intervention reduced cigarettes smoked by four, and in Denver a reduction in cotinine was reported in mothers who received the intervention. In Memphis, nurse-visited mothers reported fewer second pregnancies by 24 months post-partum (36% vs 47%). In Denver, nurse-visited mothers reported fewer subsequent pregnancies by 24 months post-partum (29% vs 41%). In 2013, a trial of the intervention in the Netherlands reported lower rates of smoking in nurse-visited women in late pregnancy.
Added value of this study
Because the programme was adapted for use in England and used young age as an enrolment criteria, we would not regard our work as a simple replication study of previous trials, although the intervention remained a licensed programme. Rather, our trial provides data for the intervention as adapted for implementation in a UK setting and delivered in a substantially diff erent publicly funded and confi gured health-care system. We show that adding the Family Nurse Partnership programme to usual care provided no additional short-term benefi t for our selected primary outcomes (smoking in pregnancy, birthweight, emergency hospital attendance and admission for the child, and subsequent pregnancy). The study fi ndings are the most directly applicable to practice and setting in the UK, where the programme is now provided in England under the operating framework for the NHS to about 16 000 concurrent women in parallel and subsequent to the trial period. The lack of benefi t evidenced for changes in smoking during pregnancy and second pregnancies therefore limits the degree to which programme benefi ts shown elsewhere can be assumed in diff erent health-care settings and to diff erent service populations, even when objective programme fi delity from US trials was maintained.
Implications of all the available evidence
Continued provision of the Family Nurse Partnership programme cannot be supported on the basis of the trial evidence found for its eff ectiveness in the UK setting. Subsequent changes to the intervention itself, to usually provided care, or to the population targeted would justify re-examination. Similarly, any positive benefi ts observed through longer-term follow-up of the current trial cohort might shift the evidentiary balance in favour of the intervention and warrants continued evaluation of the trial cohort. Nevertheless, the overall level of unaddressed clinical need such as smoking in pregnancy (56%) and rate of subsequent pregnancies (66%) remains high in this population and a public health challenge that remains unresolved.
local National Health Service (NHS) organisations and local authorities. Sites applied to the Department for Health to deliver FNP and additionally to participate in the trial with selection against set eligibility criteria (appendix).
To be eligible, women had to be nulliparous, aged 19 years or younger, living within the catchment area of a local FNP team, of less than 25 weeks' gestation, and able to provide consent and speak English. Women expecting multiple births and those with a previous pregnancy ending in miscarriage, stillbirth, or termination were eligible. Women planning to have their child adopted or to move outside of the FNP catchment area for longer than 3 months were not eligible. Women were identifi ed and approached via local maternity services and recruited usually at their home by locally based researchers. The study was approved by the Wales NHS Research Ethics Committee (09/MRE09/08) and received governance approval from all participating NHS sites. All women provided written informed consent.
Randomisation and masking
Women were randomly assigned to FNP or usual care, with randomisation stratifi ed by site and minimised by gestation (<16 weeks vs ≥16 weeks), smoking (yes vs no), and preferred language of data collection (English vs non-English) and weighted towards minimising the imbalance in trial groups with probability 0·8. The allocation programme was created by a programmer at the Bristol Randomised Trials Collaboration, a registered Clinical Trials Unit, and allocation was concealed using a remote computer-based system, accessible via telephone and internet by the recruiting researcher. Mothers and fi eldbased researchers (even if also assessors) were not masked to group allocation, but assessors collecting data by computer-assisted telephone interview were masked to allocation.
Procedures
FNP involves up to 64 structured home visits by specially recruited and trained family nurses (appendix). Developed in the USA for fi rst-time pregnant women, it was adapted under licence for delivery in England from early pregnancy until children were 2 years old. FNP aims to aff ect risks and protective factors within prenatal health-related behaviours, sensitive and competent caregiving, and early parental lifecourse. Core specialist training for nurses includes motivational interviewing and the adoption of a guiding autonomy-supportive communication style with clients.
All participants (both groups) were eligible to receive usually provided publicly funded health and social care. This included the HCP (universally off ered screening, education, immunisation, and support from birth to the child's second birthday) delivered by either family nurses (FNP group) or specialist community public health nurses (usual care group), and maternity care appropriate to clinical need. Routine data were collected by fi eld-based researchers from maternity units, by direct data download by a trial statistician from the Health and Social Care Information Centre (HSCIC), by fi eld-based researchers or practice staff from primary care centres, from the Abortions Statistics Manager at the Department of Health for abortion statistics, and from COVER (Coverage Of Vaccination Evaluated Rapidly) contacts directly from primary health-care authorities and used to obtain information about birthweight, emergency department attendances and admissions and second pregnancies, as well as for some secondary outcomes. Additionally, information about emergency department attendance and admissions, and second pregnancies was collected by maternal report. Information about tobacco use was collected by self-report and from urine samples. Selfreport data for secondary outcomes (appendix) were collected at baseline (before allocation) and 24 months post-partum by local researchers using a face-to-face structured computer-assisted personal interview; interviewers were not blinded to allocation but independent of service provision. Offi ce-based researchers who were blind to allocation used computerassisted telephone interviews to collect self-reported data at late pregnancy (34-36 weeks' gestation), and 6, 12 and 18 months post-partum.
Urine samples for cotinine assay were obtained during the baseline interview and at late pregnancy (34-36 weeks' gestation). At both timepoints women were categorised as non-smokers if they reported not smoking in the 3 days before interview and had a urinary cotinine concentration lower than 100 ng/mL. When only baseline cotinine concentrations were available, women reporting not smoking at late pregnancy and who were classifi ed as either accurate or over-reporters of tobacco use (from comparing baseline self-report and cotinine concentrations; appendix) were also categorised as non-smokers. All other women were categorised as smokers in the primary analysis.
To measure the number of contacts between women and support workers in both groups, mothers reported access to health care during the trial (including visits from community midwives and health visitors) and family nurses reported contact with their clients.
Participants were able to withdraw at any time and had the right to withdraw use of data already collected. Women who wanted to discontinue the intervention were off ered the opportunity to still provide follow-up data. All participants who had not formally withdrawn were asked if they would complete the 24 month post-partum assessment, even if they had previously not responded to data collection in preceding waves of follow-up. Women were regarded as mandatory withdrawals should miscarriage, death, or adoption of the child occur. Adverse events notifi ed to the trials offi ce by standard reporting template were reviewed by a senior clinical researcher (JS) to establish relatedness and severity.
Outcomes
Primary outcomes were tobacco use at late pregnancy (34-36 weeks' gestation), birthweight, emergency attendances and hospital admissions for the infant within 24 months of birth, and the proportion of women with a second pregnancy within 24 months post-partum (appendix). Secondary prespecifi ed outcomes were collected for many measures of pregnancy and birth, child health and development, and parental lifecourse from late pregnancy up to 24 months post-partum; a full list is in the appendix and the published protocol. 26 Adverse events were reported via standard template and were categorised as an adverse event, serious adverse event, and expected serious adverse event (appendix).
Statistical analysis
We estimated eff ect sizes detectable given the number of available sites, recruitment period, and eligibility, consent, and follow-up rates. We calculated that a sample of 1418 women was needed to provide at least 90% power at the two-sided 2·5% α level to detect diff erences between trial groups of 10% (30% vs 40%) in proportion having any emergency attendance or hospital admission, and of 7·5% (12·5% vs 20·0%) in proportions of women with a second pregnancy by 24 months post-partum (ie, one child and one maternal outcome). We allowed for a pregnancy loss of 1·5% on the basis of clinically informed estimates (>16 week miscarriage rate of around 1%, terminations for fetal anomalies 0·02%, and a stillbirth rate of 0·5%) in our calculations. We expected to obtain follow-up data for three primary outcomes for 90% of participants using medical records. Therefore, we aimed to recruit 1600 pregnant women. We chose a 2·5% α level to allow for multiple primary outcomes within each individual population (ie, two primary outcomes each for mother and child).
All analyses were done by intention to treat without imputation, with outcome values compared between groups using mixed-eff ects three-level regression models to adjust for site as a stratifi cation variable and to allow for clustering by a family nurse in the intervention group. When clustering was negligible in the FNP group at level of family nurse, as assessed by the Family Nurse level variance component from the three-level model, the simpler two-level model was used. Models were also adjusted for minimisation variables. For continuous outcomes, we fi tted a linear-regression model and presented results as diff erence in adjusted means (FNP minus usual care). Estimates were obtained using restricted maximum likelihood. For binary outcomes a logistic model was used and the result presented as adjusted odds ratios (ORs) comparing the odds of an event in FNP compared with usual care group. Count data were analysed using a Poisson multilevel model or a negative binomial model if overdispersion was evident.
Where applicable, an analysis of covariance model was used with baseline measurement as a covariate. Where data were collected over several timepoints, a repeated measures model (using a generalised linear mixed model) was used with timepoints (6, 12, 18, and 24 months) nested within participants (nested within family nurse and site) and included an interaction term for time and trial group to investigate any divergent or convergent pattern in outcomes. The global interaction eff ect was tested and was in all cases non-signifi cant, and the interaction and time term were both dropped from the model. Both the intercepts and slopes of participants' measures were allowed to vary randomly when possible. Various hierarchies were investigated, and the Akaike information criterion (AIC) used to establish the best fi tting model.
We estimated costs per participant (including all healthrelated costs and intervention costs) from the perspective of the NHS and personal social services and discounted where appropriate. We did multiple imputation to allow for missing data and sensitivity analysis to assess robustness of results from this and other assumptions.
We assessed intervention delivery against FNPspecifi ed fi delity goals including gestation at programme enrolment, number of valid visits received, attrition rates, visit duration, and coverage of planned visit content (appendix). Additional qualitative and quantitative substudies were also done to map usual care and assess use of motivational interviewing in routine FNP consultations, programme clients' experience, and perspectives of professionals (health visitors, midwives, and family nurses), but these are reported separately.
Analyses were done by two statisticians (RC-J and ZESR) using SPSS version 20 and Stata version 13. An independent data monitoring committee, reporting to an independent steering committee, oversaw the study. The trial is registered at the ISRCTN registry, number ISRCTN23019866.
Role of the funding source
The Department of Health (England) commissioned and funded the study, managed the grant application process, and acted as sponsor. The funder required the inclusion of specifi ed policy-relevant primary outcomes and determined the number of study sites, but played no role in fi nalising study design, data collection, data analysis, data interpretation, or report writing. The corresponding author had full access to all study data, vouches for data accuracy and completeness, and had fi nal responsibility for the decision to submit for publication.
Results
Between June 16, 2009, and July 28, 2010, 3251 women were screened (fi gure). 1645 women were recruited, with fi ve subsequently excluded due to non-eligibility. 22 women who chose to withdraw also removed consent for use of their data. 121 women had withdrawn by late pregnancy and a further 72 subsequently, either electively or mandatorily, hence 215 women withdrew in total. Baseline characteristics were well balanced between trial For full study report see http://bit.ly/buildingblockstrial groups (table 1). Numbers entered for analysis diff ered according to timing of planned assessment and data source (fi gure). 24 month post-partum participant assessments were completed by April 24, 2013, and HSCIC data retrieved by April 25, 2014.
The proportion of mothers who smoked at late pregnancy did not diff er between women assigned to FNP (56%) and those assigned to usual care (56%) for those with a calibrated smoking score (adjusted OR 0·90, 97·5% CI 0·64-1·28; table 2). This fi nding was robust to sensitivity analyses, which included only women with complete self-report data and recorded cotinine concentrations at both baseline and follow-up (n=870; appendix). Reported number of cigarettes smoked per day at late pregnancy did not diff er between groups for women (n=610) classifi ed at baseline as smokers (adjusted diff erence in means 0·12 cigarettes, 97·5% CI -0·73 to 0·97; table 2). Mean birthweights of babies were 3217·4 g (SD 618·0 g) for babies of women assigned to FNP and 3197·5 g (581·5 g) for those of women assigned to usual care, an adjusted diff erence of 20·75 g (97·5% CI -47·73 to 89·23). The proportion of women with a second pregnancy within 24 months of their fi rst child's birth did not diff er between the FNP (66%) and usual care (66%) groups, with an adjusted OR of 1·01 (97·5% CI 0·77-1·33; table 2). Sensitivity analyses for second pregnancy are in the appendix. Rates of emergency attendances or hospital admissions within 24 months of birth included in the analysis were 81% for FNP and 77% usual care group (OR 1·32, 97·5% CI 0·99-1·76). No diff erential eff ects due to maternal age, deprivation, participation in employment, education or training, or basic life skills were found for any primary outcome in planned subgroup analyses.
Some secondary outcomes suggested small positive impacts of the FNP (appendix). These were intentionto-breastfeed, maternally reported child cognitive development (at 24 months only), language development using a modifi ed maternal-reported assessment (at 12 and 18 months) and using a standardised assessment (the Early Language Milestone; at 24 months), levels of social support, partner-relationship quality, and general self-effi cacy. A full-sample base case analysis (782 in FNP group vs 786 in usual care group) with use of multiple imputation showed an incremental cost for FNP of £1993 per participant. Although individual types of resource use were similar across trial groups, intervention delivery costs (FNP calls and visits) accounted for the substantial incremental cost of FNP. Sensitivity analysis that included complete cases only (217 in FNP group vs 186 in usual care group) suggested the incremental cost of the FNP was £4670 (95% CI 3322-6017).
Rates of child safeguarding concerns documented in
The sample was similar to other populations of women off ered FNP in non-trial sites in England, and in trial sites after the closure of the trial (appendix). Attrition at key assessments (24 month interview, smoking) resulted in mostly small diff erences in women not included in analysis between groups (appendix). The delivery of FNP assessed against programme fi delity goals is described in the appendix.
The proportion of participants with at least one serious adverse event (mainly clinical events associated with pregnancy and infancy period) was similar (310 [38%] of 808 mother-child dyads in the usual care group vs 357 [44%] of 810 participants in the FNP group) and no events were considered related to the intervention.
Discussion
In this randomised controlled, pragmatic trial, we show no evidence of benefi t from FNP for smoking cessation, birthweight, rates of second pregnancies, and emergency hospital visits for the child (table 2) . Between-group diff erences were shown in a few secondary outcomes, of which there were a large number. FNP was delivered mostly in-line with FNP fi delity goals and as it could be provided in usual local NHS settings. In the absence of evidence of benefi t, the programme cannot be considered cost eff ective for the primary outcomes of most relevance to FNP-ie, smoking cessation and second pregnancies. Some short-term eff ects in the US trials were most evident in more vulnerable women (eg, with multiple risk factors or low psychological resources) at enrolment. 18, 21 In the Dutch VoorZorg trial 22 a two-stage selection process included women with multiple risk factors. In England, young maternal age was chosen as an easily measurable proxy for low income and its associated long-term adverse child outcomes. 27 This programme criterion might have resulted in greater heterogeneity and comparatively less disadvantage than in previous studies. Although the absence of any interactions suggests that broad FNP enrolment criteria did not mask intervention eff ects in subgroups defi ned by a-priori markers of vulnerability, diff erential eff ect by subgroup could be explored furtherwe did not power this study to detect such eff ects. 28 Unlike women in the US settings in which the intervention originated, teenage mothers in England can access many statutory supportive health and social services, including community based family doctors, midwives, and public-health nurses, and, in most trial sites, specialist teenage pregnancy midwives. Obstetric antenatal care, child surveillance, and access to emergency medicine were provided for usual care group participants in the US trials of NFP; however, in this UK-based trial, the extent of care provision accessible to the usual care group might have diluted any eff ect of FNP. Although our data do not quantify duration of health-care contact episodes, the overall rate of reported community midwifery contact was similar between groups. Women assigned to usual care saw health visitors eight more times than did those in the FNP group, but women assigned to FNP had had an average of 39 specialist nurse visits, each lasting on average longer than 1 h. Therefore, it is not likely that an equivalent level of health care was provided to women in the usual care group and that can itself explain a reduction in level of intervention eff ect. Further exploration of diff erential health-care provision (either usual care or FNP care) to the most vulnerable woman in our sample (who have previously been found to derive particular benefi t most from FNP) could explain the relative absence of eff ects in our trial. Data are n (%), n/N (%), or mean (SD), unless otherwise specifi ed. FNP group=Family Nurse Partnership programme plus usual care. *Adjusted for stratifi cation (site) and minimisation variables (gestational age and smoking status at recruitment, and fi rst or preferred language); one participant did not have two minimisation variables recorded and was excluded from all analyses. †Data were missing for 526 women: 421 not interviewed at late pregnancy, 40 not asked smoking questions as participant had given birth, and 65 had incomplete self-report or missing cotinine at baseline. ‡Adjusted odds ratio for FNP versus usual care. §Adjusted difference in means for FNP minus usual care. ¶Data were missing for 329 women: 154 were missing due to incomplete follow-up (withdrawals or left the general practitioner practice before 2 years no subsequent pregnancy fl agged), 175 where both maternal self-report and primary care records (taken as the most reliable sources) were missing and no subsequent pregnancy was fl agged in any of the other data sources (inpatients, outpatients, abortions). ||Data were missing for 32 children: fi ve children could not be linked to Health and Social Care Information Centre data; the remaining 27 were withdrawals that had no event recorded up to point of withdrawal. The intervention was originally developed by David Olds as the Nurse Family Partnership and adapted for use in England under licence by the Family Nurse Partnership National Unit, originally located within the Department of Health. The Department of Health commissioned the trial as the sole experimental and independent evaluation of the programme. The programme specifi cation is in part summarised by the programme's core model elements and fi delity goals. Our assessment against these targets shows that the intervention has been delivered as intended, giving us confi dence in its validity.
Eff ective planning of subsequent pregnancies should enable parents to complete education, manage work, and provide more focused parental nurture and guidance for their children. [29] [30] [31] We did not fi nd subsequent pregnancies to be more eff ectively planned in our study, reducing the potential to modify maltreatment and unintentional injury. The benefi ts of the intervention on maltreatment comes from the Elmira and Memphis studies, 18,20 evidenced through eff ect on injury and ingestions that resulted in emergency department visits, hospital admission, and length of hospital stay. 32 Higher rates of safeguarding initiation for FNP-group children in our study might have resulted from surveillance bias, with higher levels of health-care contact and nurses adopting a lower threshold for intervention. Similarly, the higher presentation rates for emergency secondary care for children of mothers in the FNP group might refl ect lower maternal thresholds for accessing care infl uenced by the FNP. Admissions rates for injuries and ingestions might be a more direct assessment of maltreatment compared with overall presentation to emergency departments. However, there remained no evidence of a diff erence between groups when we focused on this outcome (appendix). Only longer-term follow-up can establish whether any preventive eff ect exists.
Rates for all-cause attendances and admissions rates of emergency department episodes were higher than we anticipated. Factors such as changes to out-of-hours services for family doctors and diffi culties in securing appointments might have contributed to such rates, although mothers reported frequent access overall to primary care for both themselves and for their child.
The Building Blocks trial was independent of programme delivery and adequately powered to detect intervention eff ects by the child's second birthday. Routine data sources enabled high levels of ascertainment for three of the primary outcomes. Previous US trials of the intervention were single-centre studies (one semi-rural, two urban), involved a small number of nurses delivering the intervention (eg, ten in Denver, CO, USA), and led by the intervention developers. By contrast, our trial was led independently of the 131 family nurses working in locally managed teams delivering the intervention in 18 trial sites across England. Our trial therefore represents a more pragmatic evaluation of FNP compared with previous trials, which had a greater emphasis on effi cacy.
Due to the number of comparisons, conclusions must be drawn cautiously about secondary outcomes for which diff erences were shown, such as in language. Aside from safeguarding concerns, we show no evidence for diff erences between the two groups for maltreatment, prenatal health behaviour, and poor birth outcomes, all expected predictors of child neuro development by the FNP model. 33 Similarly, language and cognitive delays should be reduced by sensitive and competent caregiving. We did fi nd small improvements in maternal selfeffi cacy, social support, and relationship quality, which would be consistent with mothers providing such care. We show no evidence of diff erences in maternal-child interaction or parental-role strain between groups, although these were the only assessments of parenting that we did. The observed development benefi ts were maternally reported and might be subject to reporting bias, but the relative importance of language development and the reduction in language delay that has been previously observed by age 2 years (in the Denver trial) would warrant further assessment in an older age group.
In commissioning the trial, the Department of Health Research Programme that funded this study specifi ed inclusion of prenatal tobacco use, childhood injuries requiring emergency department attendance or admission, and interbirth interval as primary outcome domains that were considered on the basis of previous trials to be modifi able by FNP. Other primary outcomes, including birthweight, were also recommended by the meeting of an advisory committee to the funders as part of the development of the commissioning brief and included input from the representatives of the programme. Therefore, we included birthweight as a policy-relevant and readily measurable outcome that was applicable to all trial participants. It is identifi ed as an outcome addressed by the programme (eg, on the current FNP website), although we would recognise that only the Elmira effi cacy study has shown diff erences for the subgroup of younger women (as summarised in the logic model). We selected all emergency episodes as a primary outcome because we were confi dent that it could be reliably ascertained (ie, episodes of care more likely to be recorded than not, whereas reason for visit less accurately recorded), although episodes for injuries and ingestions were included as key secondary outcomes. An episode rate for all attendances can include both addressable and non-addressable reasons, hence the importance of the outcomes that focus on injury and ingestions alone. Events specifi c to injuries and ingestions therefore represent outcomes of most relevance to FNP, and clearer markers of programme impact. Focusing on injury and ingestion episodes alone in primary care, attendance of accident and emergency department, and hospital admission still did not show any group diff erence. Although length of stay has also been taken as an indicator of maltreatment, diff erences might exist between health-care settings in the UK and the USA that aff ects its interpretation. Length of stay is dependent not only on injury severity but also time and day of attendance, management required, and the availability of appropriate senior staff including anaesthetists to do relevant investigations. These considerations might distance length of stay from factors such as amounts of supervision, causative factors, or intent to injure. Although this was not recommended at commissioning, nor included as a trial outcome, it can be further explored in secondary analyses. Transparent reporting in this paper of all a-priori outcomes allows for further assessment of the relative benefi ts of the programme by policy makers and service commissioners.
In conclusion, we show substantial additional cost, no benefi t for policy relevant main outcomes, and some advantage for a few secondary outcomes for mother and child when adding FNP to existing health service provision in England. Evidence for benefi t for child developm ent outcomes would mainly arise in children after the age of 2 years, requiring longer-term follow-up for this outcome.
